Key result
Accelerometry-based 45-second squat test accurately predicts cardiorespiratory fitness in CAD patients on beta-blockers.
Why the study?
Cardiorespiratory fitness is typically measured by maximal or submaximal testing requiring specialized equipment, and a simpler method based on body motion for CAD patients taking β-blockers was needed.
Does a 45-second accelerometry-based squatting test accurately predict cardiorespiratory fitness in healthy subjects and CAD patients?
Cross-Sectional (n=48)
Does a 45-second accelerometry-based squatting test accurately predict cardiorespiratory fitness in healthy subjects and CAD patients?
Effect estimate: rcv = 0.91
A novel 45-second accelerometry-based squatting test provides an accurate, alternative method for predicting cardiorespiratory fitness in CAD patients, including those on beta-blockers.
Cardiorespiratory fitness (CRF) provides important diagnostic and prognostic information. It is measured directly via laboratory maximal testing or indirectly via submaximal protocols making use of predictor parameters such as submaximal [Formula: see text], heart rate, workload, and perceived exertion. We have established an innovative methodology, which can provide CRF prediction based only on body motion during a periodic movement. Thirty healthy subjects (40% females, 31.3 ± 7.8 yrs, 25.1 ± 3.2 BMI) and eighteen male coronary artery disease (CAD) (56.6 ± 7.4 yrs, 28.7 ± 4.0 BMI) patients performed a [Formula: see text] test on a cycle ergometer as well as a 45 second squatting protocol at a fixed tempo (80 bpm). A tri-axial accelerometer was used to monitor movements during the squat exercise test. Three regression models were developed to predict CRF based on subject characteristics and a new accelerometer-derived feature describing motion decay. For each model, the Pearson correlation coefficient and the root mean squared error percentage were calculated using the leave-one-subject-out cross-validation method (rcv, RMSEcv). The model built with all healthy individuals' data showed an rcv = 0.68 and an RMSEcv = 16.7%. The CRF prediction improved when only healthy individuals with normal to lower fitness (CRF<40 ml/min/kg) were included, showing an rcv = 0.91 and RMSEcv = 8.7%. Finally, our accelerometry-based CRF prediction CAD patients, the majority of whom taking β-blockers, still showed high accuracy (rcv = 0.91; RMSEcv = 9.6%). In conclusion, motion decay and subject characteristics could be used to predict CRF in healthy people as well as in CAD patients taking β-blockers, accurately. This method could represent a valid alternative for patients taking β-blockers, but needs to be further validated in a larger population.
No takes yet. Share an insight, caveat, or question.
Papini et al. (2017) conducted a cross-sectional in Coronary artery disease (n=48). 45-second squatting protocol with accelerometry vs. Cycle ergometer VO2peak test was evaluated on Cardiorespiratory fitness prediction accuracy (Pearson correlation rcv) (rcv = 0.91). An accelerometry-based 45-second squatting test accurately predicted cardiorespiratory fitness in male coronary artery disease patients taking beta-blockers (rcv = 0.91; RMSEcv = 9.6%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: